SeaBeLife
SeaBeLife is a drug developer aiming to block cell necrosis founded in 2019.
1
Funding Rounds
$1.3m
Money raised
Funding series
Funding Series Analysis
The company SeaBeLife has raised a total of $1.3m in funding over 1 rounds.
Key Insights:
- SeaBeLife September 2023 Seed Funding Round: $1.3m
SeaBeLife September 2023 Seed Funding Round
$1.3m